Court Recognizes Deceptive Similarity Between Defendant's AGRADINE Packaging and Plaintiff's Registered BETADINE Trade Dress, Issuing Notice and Interim Injunction
In a significant intellectual property dispute, the Delhi High Court has granted interim relief to Win Medicare Private Limited, the plaintiff, in its suit against Agrawal Drugs Private Limited, the defendant, concerning alleged trademark infringement and passing off. The case involves the plaintiff's well-known and registered trademark "BETADINE" and its distinctive trade dress, which the plaintiff contended the defendant copied in its "AGRADINE" products.
The plaintiff, incorporated in 1981 and a reputed manufacturer of medicinal and pharmaceutical products, has been using the BETADINE trademark and associated trade dress for decades. The registered marks include the word mark "BETADINE" (Registration No. 203023, dated 13.06.1961), various label/device marks (Registration Nos. 548821 to 548828, dated 11.04.1991), and the distinctive 'two stripe' device mark (Registration No. 1912791, dated 22.01.2010). The plaintiff also holds copyright registrations in the artistic works on its product labels and cartons.
The dispute arose when the plaintiff discovered that the defendant, a manufacturer of Povidone-Iodine preparations, was selling products under the name "AGRADINE" with a trade dress that allegedly imitated the plaintiff's packaging. The defendant's products appeared on popular online platforms such as 1mg and PlatinumRx. The plaintiff claimed that the defendant's packaging employed a deceptively similar colour scheme, layout, and the characteristic `two stripe' pattern-a sky-blue or red upper stripe above a navy-blue lower stripe-which has become exclusively associated with BETADINE products since the early 1990s.
The plaintiff argued that the defendant's adoption of this trade dress was not coincidental but a deliberate attempt to cause confusion among consumers, especially given that both parties operate in the same medicinal segment. The risk of consumer confusion, particularly in pharmaceutical products, was emphasized as a serious concern.
In response, the defendant denied the allegations and asserted its prior application for trademark registration of "AGRADINE" under Application No. 1583792, claiming use since 2006. However, the court clarified that such an application does not grant the defendant the right to adopt a trade dress that is deceptively similar to the plaintiff's registered marks.
The court noted the plaintiff's prior use, registration, and the well-known nature of the BETADINE trade dress. It acknowledged that the core grievance concerned the overall get-up and colour combination rather than the word mark itself. The court further stated that the defendant would be given an opportunity to be heard regarding the period and nature of its use of the impugned trade dress.
Considering the balance of convenience, the court found it tilted in favour of the plaintiff, noting that the defendant could continue to market its products under the "AGRADINE" name with a distinct packaging design. Consequently, the court issued notice to the defendant and granted an interim injunction restraining it from using the allegedly infringing trade dress until the next hearing.
The court also exempted the plaintiff from pre-litigation mediation under Section 12A of the Commercial Courts Act, 2015, citing precedents from the Supreme Court and the Delhi High Court that justified such exemption under the facts of the case.
The case is scheduled for further proceedings, including the filing of the defendant's reply and discovery of documents, with interim relief remaining in effect.
This judgment underscores the protection afforded to registered trade dress under Indian law and the courts' vigilance in preventing deceptive practices that could mislead consumers, especially in the sensitive pharmaceutical sector.
Bottom Line:
Intellectual Property - Application for interim injunction - Trademark infringement and passing off - Plaintiff's registered trademark "BETADINE" and its distinctive trade dress allegedly copied by the defendant - Court considers deceptive similarity in trade dress and balance of convenience.
Statutory provision(s):
Trade Marks Act, 1999 Sections 29, 135; Commercial Courts Act, 2015 Section 12A; Civil Procedure Code, 1908 Order 39 Rules 1 and 2, Section 151
Win Medicare Private Limited v. Agrawal Drugs Private Limited, (Delhi) : Law Finder Doc Id # 3019168